Engineered nucleic acids and methods of use thereof
US9181319B2 · kind B2 · utility
81Cited by
399References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2014 |
| Grant date | Nov 10, 2015 |
| Priority date | — |
| Expiry date | May 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compositions and methods for delivering biological moieties such as modified nucleic acids into cells to modulate protein expression. Such compositions and methods include the use of modified messenger RNAs, and are useful to treat or prevent diseases, disorders or conditions, or to improve a subject's heath or wellbeing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.